You just read:

Bragar Eagel & Squire, P.C. is Investigating Nektar Therapeutics, Inc. (NASDAQ: NKTR) on Behalf of Stockholders and Encourages Nektar Investors to Contact the Firm

News provided by

Bragar Eagel & Squire, P.C.

Aug 15, 2019, 20:35 ET